WEST COLUMBIA, S.C., June 8, 2023 /PRNewswire/ — Nephron Pharmaceuticals Corporation today announced Christopher Fortier, PharmD, FASHP, CPEL, will join as President of its 503B Outsourcing Facility. In his new role, Fortier will oversee all operations at the industry-leading facility…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.